Structures by: Chopade P. D.
Total: 57
P50 2-aminopyrazine, (4-NO2-PhCOOH)2
(C4H5N3)(C7H5NO4)2
CrystEngComm (2012) 14, 18 5845
a=13.8994(7)Å b=5.4845(3)Å c=13.1317(6)Å
α=90.00° β=101.948(2)° γ=90.00°
P55 2-aminopyrazine, 3-NO2-PhCOOH
(C4H5N3)(C7H5NO4)2
CrystEngComm (2012) 14, 18 5845
a=5.9930(10)Å b=12.1894(18)Å c=12.995(2)Å
α=90.00° β=98.803(8)° γ=90.00°
P54 2-aminopyrazine, 3,5-(NO2)2-PhCOOH
(C4H5N3)(C7H4N2O6)
CrystEngComm (2012) 14, 18 5845
a=7.6755(11)Å b=8.8822(11)Å c=9.6107(15)Å
α=84.645(10)° β=82.063(11)° γ=74.877(10)°
D3 2-aminopyrazine, HOOC-(CH2)2-COOH
(C4H5N3)2(C4H6O4)
CrystEngComm (2012) 14, 18 5845
a=5.3982(9)Å b=19.505(3)Å c=6.9524(12)Å
α=90.00° β=104.487(10)° γ=90.00°
D8 2-aminopyrazine, HOOC-(CH2)3-COOH
(C4H5N3)(C5H8O4)
CrystEngComm (2012) 14, 18 5845
a=5.2487(3)Å b=29.2633(18)Å c=7.2357(5)Å
α=90.00° β=104.958(3)° γ=90.00°
D9 2-aminopyrazine, HOOC-(CH2)5-COOH
(C4H5N3)(C7H12O4)
CrystEngComm (2012) 14, 18 5845
a=5.0231(5)Å b=34.308(3)Å c=7.4377(8)Å
α=90.00° β=102.850(5)° γ=90.00°
D4 2-aminopyrazine, HOOC-(CH2)8-COOH
(C4H5N3)(C10H18O4)
CrystEngComm (2012) 14, 18 5845
a=5.7935(6)Å b=7.5090(8)Å c=8.7271(8)Å
α=92.984(4)° β=91.952(5)° γ=98.570(5)°
D5 2-aminopyrazine, HOOC-(CH2)6-COOH
(C4H5N3)(C8H14O4)
CrystEngComm (2012) 14, 18 5845
a=7.7749(5)Å b=9.8014(7)Å c=9.2097(6)Å
α=90.00° β=101.560(3)° γ=90.00°
AR-cc-2c-10 2,6-dibromo-3-aminopyrazine, F5-PhCOOH
(C4H3N3Br2)(C7HF5O2)
CrystEngComm (2012) 14, 18 5845
a=15.5511(6)Å b=5.8057(2)Å c=16.0859(6)Å
α=90.00° β=111.0750(10)° γ=90.00°
P9 2-amino-3,5-dibromopyrazine, 3,5-(NO2)2-PhCOOH
(C4H3N3Br2)(C7H4N2O6)
CrystEngComm (2012) 14, 18 5845
a=7.3153(3)Å b=10.4607(4)Å c=10.8371(4)Å
α=65.094(2)° β=83.688(2)° γ=89.742(2)°
ARcc-2c-7 2-amino-3,5-dibromopyrazine, 2,6-difluorobenzoic acid
(C4H3N3Br2)(C7H4O2F2)
CrystEngComm (2012) 14, 18 5845
a=5.6663(5)Å b=13.2299(11)Å c=17.3426(14)Å
α=90.00° β=93.911(4)° γ=90.00°
3,3'-AzoPy-3HBXB (3-pyridyl)-N=N-(3-pyridyl), (4-I-F4-PhOH)2
(C10H8N4)(C6HF4IO)2
CrystEngComm (2013) 15, 16 3125
a=19.0228(11)Å b=16.8636(10)Å c=7.2425(4)Å
α=90.00° β=93.198(2)° γ=90.00°
3,3'-AzoPy 2-HBXB (3-pyridyl)-N=N-(3-pyridyl), (4-Br-F4- PhCOOH)2
(C10H8N4)(C7HBrF4O2)2
CrystEngComm (2013) 15, 16 3125
a=4.8724(3)Å b=22.0007(13)Å c=11.6936(7)Å
α=90.00° β=101.336(3)° γ=90.00°
3,3'-AzoPy 8-HBXB (3-pyridyl)-N=N-(3-pyridyl), (4-I-F4- PhCH=NOH)2
(C10H8N4)(C7H2F4INO)2
CrystEngComm (2013) 15, 16 3125
a=5.6341(4)Å b=10.4834(7)Å c=11.5197(8)Å
α=75.365(2)° β=77.562(2)° γ=80.975(2)°
3,3'-AzoPy 4-HBXB, (3-pyridyl)-N=N-(3-pyridyl), (4-Br-F4- PhOH)2
(C10H8N4)(C6HBrF4O)2
CrystEngComm (2013) 15, 16 3125
a=18.2149(8)Å b=16.4379(7)Å c=7.4736(4)Å
α=90.00° β=99.631(2)° γ=90.00°
C17H9BrF4N4O2
C17H9BrF4N4O2
CrystEngComm (2013) 15, 16 3125
a=10.1601(6)Å b=13.4584(8)Å c=14.4512(10)Å
α=112.181(4)° β=90.560(4)° γ=111.547(4)°
4,4'-AzoPy 3-HBXB (4-pyridyl)-N=N-(4-pyridyl), 4-I-F4-PhOH
(C10H8N4)(C6HF4IO)
CrystEngComm (2013) 15, 16 3125
a=6.1515(5)Å b=9.8197(7)Å c=13.7443(10)Å
α=81.558(3)° β=85.932(3)° γ=78.342(3)°
4,4'AzoPy 5-HBXB (4-pyridyl)-N=N-(4-pyridyl), (4-Br-F4-PhCHO oxime)2
(C10H8N4)(C7H2BrF4NO)2
CrystEngComm (2013) 15, 16 3125
a=10.2846(10)Å b=4.6215(5)Å c=27.841(2)Å
α=90.00° β=98.246(6)° γ=90.00°
3,3'-AzoPy 1-HB-XB (3-pyridyl)-N=N-(3-pyridyl), (4-I-F4- PhCOOH)2
(C10H8N4)(C7HF4IO2)2
CrystEngComm (2013) 15, 16 3125
a=4.9020(3)Å b=21.4561(12)Å c=12.1298(7)Å
α=90.00° β=100.151(2)° γ=90.00°
3,3'-AzoPy 5-HBXB (3-pyridyl)-N=N-(3-pyridyl), (4-Br-F4-PhCHO oxime)2
(C10H8N4)(C7H2BrF4NO)2
CrystEngComm (2013) 15, 16 3125
a=8.3500(8)Å b=8.3646(8)Å c=9.8996(10)Å
α=105.765(3)° β=103.151(3)° γ=99.733(3)°
4,4'-AzoPy 1-HB-XB (4-pyridyl)-N=N-(4-pyridyl), (4-I-F4- PhCOOH)
(C10H8N4)(C7HF4IO2)
CrystEngComm (2013) 15, 16 3125
a=6.2112(8)Å b=8.1879(11)Å c=8.9824(12)Å
α=84.843(3)° β=70.837(3)° γ=77.402(3)°
4,4'-AzoPy 8HBXB (4-pyridyl)-N=N-(4-pyridyl), 4-I-F4-PhCHO oxime
(C10H8N4)(C7H2F4INO)
CrystEngComm (2013) 15, 16 3125
a=17.6282(7)Å b=6.3167(3)Å c=31.7318(14)Å
α=90.00° β=96.518(2)° γ=90.00°
4,4'-AzoPy 4-HBXB (4-pyridyl)-N=N-(4-pyridyl), 4-Br-F4-PhOH
(C10H8N4)(C6HBrF4O)
CrystEngComm (2013) 15, 16 3125
a=6.3706(3)Å b=9.5670(5)Å c=13.3289(7)Å
α=79.453(2)° β=83.090(2)° γ=79.4760(10)°
A-2-6 CVT-COOH, 4,4'-bipyridyl
(C60H72O16)(C10H8N2)2(C2H3N)0.8(CH3OH)2(CH3O)1.2
CrystEngComm (2016) 18, 39 7457
a=29.225(3)Å b=11.4565(11)Å c=23.889(2)Å
α=90° β=99.091(5)° γ=90°
A-2-4 HOOC-CVT, 2-H2N-4-Cl-5-Br-6-H3C-pyrimidine
(C60H72O16)2(C5H5N3BrCl)3(H2O)4(C2H3N)8
CrystEngComm (2016) 18, 39 7457
a=14.7508(9)Å b=16.1947(10)Å c=17.6138(11)Å
α=75.197(2)° β=79.775(3)° γ=80.709(3)°
AS-15 2-(4-tolyl)-2,4-pentanedione
C12H14O2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=7.5220(8)Å b=6.6202(7)Å c=11.1582(12)Å
α=90.00° β=108.875(4)° γ=90.00°
AS-14 2-(4-chlorophenyl)-2,4-pentanedione
C11H11ClO2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=20.2258(14)Å b=6.7622(5)Å c=7.3688(5)Å
α=90.00° β=90.00° γ=90.00°
AS-5 2-(4-bromophenyl)-2,4-pentanedione
C11H11BrO2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=20.4766(18)Å b=6.8070(6)Å c=7.3506(6)Å
α=90.00° β=90.00° γ=90.00°
PC-7-3-Iacac 2-(4-iodophenyl)-2,4-pentanedione
C11H11IO2
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=21.0708(12)Å b=6.9034(4)Å c=7.3624(4)Å
α=90.00° β=90.00° γ=90.00°
AS-12 2-(4-tolyl)-2,4-pentanedione, copper(II) tetrafluoroborate
(C12H13O2)2Cu
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=11.9427(6)Å b=16.3128(8)Å c=21.4984(11)Å
α=90.00° β=90.00° γ=90.00°
AS-6 bis[2-(4-bromophenyl)-2,4-pentanedionato]copper(II)
(C11H10BrO2)2(Cu)
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=12.0389(11)Å b=15.8409(12)Å c=22.1627(17)Å
α=90.00° β=90.00° γ=90.00°
D1 bis[2-(4-chlorophenyl)-2,4-pentanedionato]copper(II)
(C11H10ClO2)2Cu
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=11.9763(7)Å b=15.8265(9)Å c=21.7849(11)Å
α=90.00° β=90.00° γ=90.00°
AS-10 2-(4-iodophenyl)-2,4-pentanedione, copper(II) nitrate
(C11H10IO2)2Cu
Dalton transactions (Cambridge, England : 2003) (2011) 40, 45 12160-12168
a=8.2510(4)Å b=7.7262(4)Å c=17.8085(10)Å
α=90.00° β=101.525(3)° γ=90.00°
P60 2-aminopyrazine, 4-I-F4-PhCOOH
C4H5N3,C7HIF4O2
Chem.Commun. (2011) 47, 4688
a=15.2832(8)Å b=11.5421(6)Å c=15.3499(8)Å
α=90.00° β=107.171(2)° γ=90.00°
P59 2-aminopyrazine, 4-bromotetrafluorobenzoic acid
C4H5N3,C7HBrF4O2
Chem.Commun. (2011) 47, 4688
a=10.6236(4)Å b=10.6899(4)Å c=22.3295(9)Å
α=84.593(2)° β=76.279(2)° γ=90.002(2)°
PC-4-7b 2-amino-5-bromopyrazine, 4-I-F4-PhCOOH
C4H4BrN3,C7HF4IO2
Chem.Commun. (2011) 47, 4688
a=14.3341(10)Å b=14.1571(10)Å c=6.8919(5)Å
α=90.00° β=96.564(3)° γ=90.00°
P10 3-amino-2,6-dibromopyrazine, 4-I-F4-PhCOOH
C4H3Br2N3,C7HF4IO2
Chem.Commun. (2011) 47, 4688
a=10.4824(4)Å b=5.7580(3)Å c=25.7816(11)Å
α=90.00° β=98.9360(10)° γ=90.00°
P39 4-Br-2,3,5,6-F4-PhCOOH, 2-Br-5-NH2-pyrazine
C7HBrF4O2,C4H4BrN3
Chem.Commun. (2011) 47, 4688
a=7.1539(4)Å b=9.6066(5)Å c=10.2884(6)Å
α=89.546(4)° β=73.888(3)° γ=83.695(3)°
PC-4-7d 2-amino-3,5-dibromopyrazine, 4-Br-F4-PhCOOH
C4H3Br2N3,C7HBrF4O2
Chem.Commun. (2011) 47, 4688
a=15.2443(14)Å b=13.9577(16)Å c=21.995(3)Å
α=90.00° β=109.743(6)° γ=90.00°
CVT-53-B2 bromo pentyl ethylene cavitand
(C56H68Br4O8)2(C2H3N1)5
CrystEngComm (2014) 16, 18 3796
a=14.9430(6)Å b=17.0436(7)Å c=26.1853(11)Å
α=101.948(2)° β=97.566(2)° γ=111.014(2)°
CJ-1 ethano 3-pyridyl CVT, (ethanol)9
(C76H84N4O8)2(C2H6O)9
CrystEngComm (2014) 16, 18 3796
a=12.7536(6)Å b=13.7525(7)Å c=24.5901(12)Å
α=105.279(2)° β=95.784(2)° γ=102.120(2)°
P-1-5 [tetra(3-pyridyl) CVT]2, (4-NO2-PhCOOH)8 (PhNO2)5 (H2 O)2
(C76H84N4O8)2(C7H5NO4)8(C6H5NO2)5(H2O)2
CrystEngComm (2014) 16, 18 3796
a=13.3210(9)Å b=52.697(4)Å c=16.3401(11)Å
α=90.00° β=109.773(3)° γ=90.00°
PC-4-55-5 (4-Br-F4-phenyl)-4-I-F4-benzamide, 1,2-bis(4-pyridyl)ethane
(C13HBrF8INO)(C12H12N2)
Crystal Growth & Design (2013) 13, 9 4145
a=15.2758(8)Å b=7.9588(4)Å c=20.3245(10)Å
α=90.00° β=99.899(2)° γ=90.00°
PC-4-55-8 (4-Br-F4-phenyl)-4-I-F4-benzamide, 1,2-bis(4-pyridyl)ethylene
(C13HBrF8IN)(C12H10N2O)
Crystal Growth & Design (2013) 13, 9 4145
a=4.6568(3)Å b=11.0639(6)Å c=12.2258(7)Å
α=98.373(2)° β=100.443(2)° γ=97.995(2)°
PC-4-55-6 (4-Br-F4-phenyl)-4-I-F4-benzamide, 4,4-bipyridyl
(C13HBrF8INO)2(C10H8N2)
Crystal Growth & Design (2013) 13, 9 4145
a=4.7774(7)Å b=7.9111(10)Å c=25.928(4)Å
α=89.199(8)° β=85.294(9)° γ=75.073(8)°
PC-4-10e (2-aminopyrazine)2, 1,4-diiodotetrafluorobenzene
(C4H5N3)2(C6I2F4)
Crystal Growth & Design (2011) 11, 12 5333
a=7.9013(6)Å b=5.6116(4)Å c=20.1258(16)Å
α=90.00° β=101.260(4)° γ=90.00°
4-11e 2-amino-5-bromopyrazine, 1,4-diiodotetrafluorobenzene
(C4H4N3Br)2(C6F4I2)
Crystal Growth & Design (2011) 11, 12 5333
a=5.6316(6)Å b=8.1219(9)Å c=21.226(2)Å
α=90.00° β=93.035(4)° γ=90.00°
4-12e (3-amino-2,6-dibromopyrazine)2, 1,4-diiodotetrafluorobenzene
(C4H3N3Br2)2(C6F4I2)
Crystal Growth & Design (2011) 11, 12 5333
a=5.6428(4)Å b=9.7705(7)Å c=10.4014(7)Å
α=100.821(3)° β=103.743(3)° γ=93.752(3)°
PC-4-43-6 1-bromo-4-iodotetrafluorobenzene, (2,3,5,6-tetramethylpyrazine)2
(C6BrF4I)(C8H12N2)2
Crystal Growth & Design (2013) 13, 9 4145
a=7.0820(4)Å b=9.4394(5)Å c=9.9426(6)Å
α=70.354(2)° β=69.519(2)° γ=83.639(2)°
PC-4-45-6 1-I-4-(4-Br-F4-phenyl)-F4-benzene, 2,3,5,6-Me4-pyridine
(C12BrF8I)(C8H12N2)
Crystal Growth & Design (2013) 13, 9 4145
a=13.6678(7)Å b=13.8355(8)Å c=11.3735(6)Å
α=90.00° β=104.064(2)° γ=90.00°
J3 1-bromo-4-iodotetrafluorobenzene, 2,3,5,6-Me4-pyridine-1-oxide
(C6BrF4I)(C8H12N2O)
Crystal Growth & Design (2013) 13, 9 4145
a=14.121(6)Å b=4.3893(17)Å c=14.377(6)Å
α=90.00° β=109.448(6)° γ=90.00°
PC-3-86a N-(4-I-phenyl)-4-Br-F4-benzamide
C13H5BrF4INO
Crystal Growth & Design (2013) 13, 9 4145
a=7.1847(7)Å b=25.234(3)Å c=8.0401(8)Å
α=90.00° β=107.157(5)° γ=90.00°
PC-4-45-3 1-iodo-4-(4-bromotetrafluorophenyl)-tetrafluorobenzene, 4-(1-pyrrolidinyl)-pyridine
(C12BrF8I)(C9H12N2)
Crystal Growth & Design (2013) 13, 9 4145
a=13.3208(8)Å b=23.8060(14)Å c=7.8323(4)Å
α=90.00° β=123.017(3)° γ=90.00°
PC-4-45-2 1-iodo-4-(4-bromotetrafluorophenyl)-tetrafluorobenzene, 4-(dimethylamino)pyridine
(C12BrF8I)(C7H10N2)
Crystal Growth & Design (2013) 13, 9 4145
a=7.7850(5)Å b=11.3455(7)Å c=12.8117(9)Å
α=114.949(3)° β=95.310(3)° γ=90.597(3)°
P13 2,6-Br2-3-NH2-pyrazine, 2,5-(HO)2-PhCOOH
(C4H3N3Br2)(C7H6O4)
CrystEngComm (2012) 14, 18 5845
a=6.8754(7)Å b=7.1197(7)Å c=13.8665(14)Å
α=87.951(3)° β=86.435(3)° γ=72.915(4)°
J1 1-bromo-4-iodotetrafluorobenzene, 4,4'-bipyridyl-1-oxide
(C6BrF4I)(C10H8N2O)
Crystal Growth & Design (2013) 13, 9 4145
a=4.0681(3)Å b=13.2198(9)Å c=16.4160(11)Å
α=107.014(4)° β=91.675(3)° γ=98.090(4)°
PC-4-45-11 1-I-4-(4-Br-F4-phenyl)-F4-benzene, 1-[(4-pyridyl)methyl]-5,6-dimethylbenzimidazole
(C12BrF8I)(C15H15N3)
Crystal Growth & Design (2013) 13, 9 4145
a=9.1185(7)Å b=10.8775(9)Å c=13.8025(11)Å
α=80.633(3)° β=71.005(3)° γ=83.608(4)°